SWM
ALNY icon

SeaCrest Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

SeaCrest Wealth Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300
Closed -$44K – 656
2022
Q2 		$44K Buy
+300
New +$42.6K 0.01% 1170
2019
Q2 		– Sell
-400
Closed -$37K – 567
2019
Q1 		$37K Hold
400
– – 0.01% 1046
2018
Q4 		$29K Hold
400
– – 0.01% 1087
2018
Q3 		$35K Buy
400
+100
+33% +$10.1K 0.01% 1141
2018
Q2 		$30K Sell
300
-100
-25% -$9.92K 0.01% 1186
2018
Q1 		$48K Hold
400
– – 0.01% 964
2017
Q4 		$51K Buy
+400
New +$50.3K 0.01% 948

Other funds holding ALNY

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return